Purchase Order HT001426PE040

The Defense Health Agency awarded a $40.2K firm fixed-price purchase order to INO Therapeutics LLC for nitric oxide gas, with a performance location in Bethesda, Maryland and an ultimate completion date of January 31, 2027. This contract represents a child order under INO Therapeutics' larger Blanket Purchase Agreement with the Defense Health Agency, which was established on March 20, 2025, with a $404.2K ceiling value through March 19, 2030. No small business set-aside was applied to this award. The contract procures inhaled nitric oxide therapeutic gas supplies essential for critical care respiratory treatments, including INOMAX cylinders and related delivery systems that support patient care across federal military medical facilities.

INO Therapeutics LLC, a foreign-owned, for-profit organization headquartered in Hazelwood, Missouri, brings extensive federal contracting experience as a specialized supplier of therapeutic medical gases and inhalation therapy services to the Department of Veterans Affairs and Defense Health Agency. The company maintains three active blanket purchase agreements across multiple Veterans Integrated Service Networks and federal agencies, having successfully delivered nitric oxide gas supplies and respiratory therapy services to prominent military medical centers including Walter Reed National Military Medical Center, Tripler Army Medical Center, and Naval Medical Center San Diego. This purchase order reflects the company's established role as a critical supplier of advanced respiratory treatments for neonatal, pediatric, and adult patient populations throughout the federal healthcare system.